Eddahibi S, Fabre V, Boni C, Martres M P, Raffestin B, Hamon M, Adnot S
Département de Physiologie, INSERM U492, Créteil, France.
Circ Res. 1999 Feb 19;84(3):329-36. doi: 10.1161/01.res.84.3.329.
-The increased delivery of serotonin (5-hydroxytryptamine, 5-HT) to the lung aggravates the development of hypoxia-induced pulmonary hypertension in rats, possibly through stimulation of the proliferation of pulmonary artery smooth muscle cells (PA-SMCs). In cultured rat PA-SMCs, 5-HT (10(-8) to 10(-6) mol/L) induced DNA synthesis and potentiated the mitogenic effect of platelet-derived growth factor-BB (10 ng/mL). This effect was dependent on the 5-HT transporter (5-HTT), since it was prevented by the 5-HTT inhibitors fluoxetine (10(-6) mol/L) and paroxetine (10(-7) mol/L), but it was unaltered by ketanserin (10(-6) mol/L), a 5-HT2A receptor antagonist. In PA-SMCs exposed to hypoxia, the levels of 5-HTT mRNA (measured by competitive reverse transcriptase-polymerase chain reaction) increased by 240% within 2 hours, followed by a 3-fold increase in the uptake of [3H]5-HT at 24 hours. Cotransfection of the cells with a construct of human 5-HTT promoter-luciferase gene reporter and of pCMV-beta-galactosidase gene allowed the demonstration that exposure of cells to hypoxia produced a 5.5-fold increase in luciferase activity, with no change in beta-galactosidase activity. The increased expression of 5-HTT in hypoxic cells was associated with a greater mitogenic response to 5-HT (10(-8) to 10(-6) mol/L) in the absence as well as in the presence of platelet-derived growth factor-BB. 5-HTT expression assessed by quantitative reverse transcriptase-polymerase chain reaction and in situ hybridization in the lungs was found to predominate in the media of pulmonary artery, in which a marked increase was noted in rats that had been exposed to hypoxia for 15 days. These data show that in vitro and in vivo exposure to hypoxia induces, via a transcriptional mechanism, 5-HTT expression in PA-SMCs, and that this effect contributes to the stimulatory action of 5-HT on PA-SMC proliferation. In vivo expression of 5-HTT by PA-SMC may play a key role in serotonin-mediated pulmonary vascular remodeling.
-血清素(5-羟色胺,5-HT)向肺的递送增加会加重大鼠缺氧诱导的肺动脉高压的发展,可能是通过刺激肺动脉平滑肌细胞(PA-SMCs)的增殖实现的。在培养的大鼠PA-SMCs中,5-HT(10⁻⁸至10⁻⁶mol/L)诱导DNA合成,并增强血小板衍生生长因子-BB(10 ng/mL)的促有丝分裂作用。这种作用依赖于5-HT转运体(5-HTT),因为它被5-HTT抑制剂氟西汀(10⁻⁶mol/L)和帕罗西汀(10⁻⁷mol/L)所阻断,但不受5-HT₂A受体拮抗剂酮色林(10⁻⁶mol/L)的影响。在暴露于缺氧环境的PA-SMCs中,通过竞争性逆转录聚合酶链反应测量的5-HTT mRNA水平在2小时内增加了240%,随后在24小时时[³H]5-HT摄取增加了3倍。将细胞与人5-HTT启动子-荧光素酶基因报告基因构建体和pCMV-β-半乳糖苷酶基因共转染,结果表明细胞暴露于缺氧环境会使荧光素酶活性增加5.5倍,而β-半乳糖苷酶活性没有变化。缺氧细胞中5-HTT表达的增加与在不存在和存在血小板衍生生长因子-BB的情况下对5-HT(10⁻⁸至10⁻⁶mol/L)的更大促有丝分裂反应相关。通过定量逆转录聚合酶链反应和原位杂交评估发现,肺中5-HTT的表达在肺动脉中膜占主导,在暴露于缺氧15天的大鼠中,肺动脉中膜的5-HTT表达显著增加。这些数据表明,体外和体内暴露于缺氧环境通过转录机制诱导PA-SMCs中5-HTT的表达,并且这种作用有助于5-HT对PA-SMC增殖的刺激作用。PA-SMCs在体内表达5-HTT可能在血清素介导的肺血管重塑中起关键作用。